Posts Tagged :

Specialty Pharmacy Trends

Ambulatory Clinical Pharmacist Impact on Coverage Outcomes for Speciatly Oncology Medications 216 115 Shields Health Solutions

Ambulatory Clinical Pharmacist Impact on Coverage Outcomes for Speciatly Oncology Medications

    This poster evaluates the cimpact of an ACP program on third party pharmacy coverage determination outcomes for specialty oncology medications prescribed from these clinics.  

Clinical, Safety, and Quality Outcomes of a Hypertrophic Cardiomyopathy Clinical Pharmacy Management Program 216 115 Shields Health Solutions

Clinical, Safety, and Quality Outcomes of a Hypertrophic Cardiomyopathy Clinical Pharmacy Management Program

    This poster evaluates the clinical, safety, and quality outcomes of a pharmacist-led HCM clinical management program.  

Analysis of Oral Oncolytic Waste for Patients Filling at a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Analysis of Oral Oncolytic Waste for Patients Filling at a Health System Specialty Pharmacy

    This poster evaluates existing oral oncology medication waste events among patients filling at a HSSP.  

Unlocking the Full Potential of Your DIY Specialty Pharmacy Program: Why Strategic Partnership Matters 70 70 Shields Health Solutions

Unlocking the Full Potential of Your DIY Specialty Pharmacy Program: Why Strategic Partnership Matters

Specialty pharmacy is one of the fastest-growing and most essential parts of today’s healthcare landscape — and you’re likely already feeling both the opportunity and the pressure. As the number…

How CHRISTUS Health Reimagined Diabetes Support Through Health System Specialty Pharmacy 70 70 Shields Health Solutions

How CHRISTUS Health Reimagined Diabetes Support Through Health System Specialty Pharmacy

This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy 70 70 Shields Health Solutions

Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy

  According to the CDC, approximately 38 million Americans have diabetes (about 1 in 10) and approximately 90-95% of those have type 2 diabetes. GLP-1 and GLP-1/GIP agonists are now recognized…

Addressing GLP-1 Access and Adherence Challenges with Specialty Pharmacy Solutions 70 70 Shields Health Solutions

Addressing GLP-1 Access and Adherence Challenges with Specialty Pharmacy Solutions

Whether through social media, traditional news outlets, or word of mouth, discussions about GLP-1 therapy are everywhere. These medications, originally approved by the FDA for the treatment of Type 2…

Asembia Specialty Pharmacy Summit: Location, Dates, What to Expect, and What’s Happening 70 70 Shields Health Solutions

Asembia Specialty Pharmacy Summit: Location, Dates, What to Expect, and What’s Happening

Every year, more than 8,000 professionals and over 1,400 companies attend the leading specialty pharmacy conference in the nation, Asembia Summit 2024 marked its 20th anniversary — and we couldn’t be…

Shields Outcomes 2024 Report 70 70 Shields Health Solutions

Shields Outcomes 2024 Report

This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy

This poster evaluates the clinical and quality outcomes of a bleeding disorder program at a health system HSSP.